充電最適化は,コリスマートミュータゼ阻害体の効能と選択性を高めます
1Laboratorium für Organische Chemie, Swiss Federal Institute of Technology, ETH Hönggerberg, CH-8093 Zürich, Switzerland.
Journal of the American Chemical Society
|May 8, 2003
まとめ
計算による電荷最適化により,コリスマートミュータゼ抑制が改善されました. ディカルボキシラート阻害剤をニトログループで改変することで,バシルス・サブティリス・コレズマート変異酶 (BsCM) に対する効能と選択性が向上しました.
科学分野:
- バイオケミストリー バイオケミストリー
- コンピューティング・ケミストリー
- 酵素阻害は酵素を抑制する.
背景:
- コリスマートミュータゼは,シキマート経路における重要な酵素である.
- トランジション状態のアナログ阻害剤は,酵素機構を研究するための貴重なツールです.
- コンピューティング・メソッドは,改良された酵素阻害剤の設計を導くことができます.
研究 の 目的:
- 高アフィニティのコリスマート変異酵素阻害剤を計算的に最適化するために.
- 酵素阻害アッセイを通じて,計算上の予測を実験的に検証する.
- 改変が阻害剤の効能および選択性に与える影響を評価する.
主な方法:
- ディカルボキシラートトランジション状態のアナログ阻害剤の計算式電荷最適化.
- ニトログループ置換による改変した阻害剤の合成.
- 酵素阻害アッセイでは,バシルス・サブティリス・コリスマート・ミュータゼ (BsCM) とエシェリキア・コライ・コリスマート・ミュータゼ (EcCM) を使用しています.
- 切断されたBsCMの変種を用いた実験で,C端末の相互作用を調査した.
主要な成果:
- 窒素置換阻害剤は,BSCMに対する効能が3倍に増加したことを示した.
- 酵素切断実験では,C端末と阻害剤との良好な相互作用が明らかになった.
- ニトロ誘導体は,EcCMよりもBsCMに10倍以上の選択性を示した.
- 実験結果は,計算による予測とほぼ一致していた.
結論:
- 計算による電荷最適化は,強力で選択的な酵素阻害剤を設計するための実行可能な戦略です.
- この研究は,酵素の柔軟性と特定のアミノ酸の相互作用が,阻害剤結合における重要性を強調しています.
- 改造された阻害剤は,コリスマート変異酶を標的とした重要な進歩を表しています.
関連する概念動画
02:19Buffer Effectiveness
Buffer solutions do not have an unlimited capacity to keep the pH relatively constant . Instead, the ability of a buffer solution to resist changes in pH relies on the presence of appreciable amounts of its conjugate weak acid-base pair. When enough strong acid or base is added to substantially lower the concentration of either member of the buffer pair, the buffering action within the solution is compromised.
The buffer capacity is the amount of acid or base that can be added to a given volume...
The buffer capacity is the amount of acid or base that can be added to a given volume...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
01:31Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...